GR3006147T3 - - Google Patents

Info

Publication number
GR3006147T3
GR3006147T3 GR910402076T GR910402076T GR3006147T3 GR 3006147 T3 GR3006147 T3 GR 3006147T3 GR 910402076 T GR910402076 T GR 910402076T GR 910402076 T GR910402076 T GR 910402076T GR 3006147 T3 GR3006147 T3 GR 3006147T3
Authority
GR
Greece
Prior art keywords
compounds
diseases
cardiac
hypertension
act
Prior art date
Application number
GR910402076T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006147T3 publication Critical patent/GR3006147T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR910402076T 1986-06-24 1992-11-05 GR3006147T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863621104 DE3621104A1 (de) 1986-06-24 1986-06-24 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
GR3006147T3 true GR3006147T3 (el) 1993-06-21

Family

ID=6303566

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910402076T GR3006147T3 (el) 1986-06-24 1992-11-05

Country Status (15)

Country Link
US (1) US4757080A (el)
EP (1) EP0250725B1 (el)
JP (1) JPS635089A (el)
KR (1) KR880000422A (el)
AT (1) ATE82016T1 (el)
AU (1) AU586557B2 (el)
DE (2) DE3621104A1 (el)
DK (1) DK314587A (el)
ES (1) ES2044853T3 (el)
GR (1) GR3006147T3 (el)
HU (1) HU197895B (el)
IL (1) IL82317A (el)
NZ (1) NZ220539A (el)
PT (1) PT85098B (el)
ZA (1) ZA872863B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19617606A1 (de) * 1996-05-02 1997-11-06 Wacker Chemie Gmbh Kontinuierliches Verfahren zur Herstellung lagerstabiler Organopolysiloxanzusammensetzungen
JP4898397B2 (ja) * 2006-11-21 2012-03-14 株式会社Ａｃｃｕｒａｔｅ 排水管内清掃装置及び排水管内清掃方法
WO2012069989A1 (en) * 2010-11-23 2012-05-31 Cadila Pharmaceuticals Limited Process for preparation of clevidipine and its intermediate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives
DK221081A (da) * 1980-05-31 1981-12-01 Smith Kline French Lab Fremgangsmaade til fremstilling af heterocyklylalkylanidiner mellemprodukter til anvendelse ved denne fremgangsmaade og en fremgangsmaade til fremstilling af disse mellemprodukter
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
JPS60226876A (ja) * 1984-04-25 1985-11-12 Kowa Co １，４−ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
AU586557B2 (en) 1989-07-13
IL82317A (en) 1991-06-10
HU197895B (en) 1989-06-28
DE3782457D1 (de) 1992-12-10
PT85098A (de) 1987-07-01
DE3621104A1 (de) 1988-01-07
IL82317A0 (en) 1987-10-30
KR880000422A (ko) 1988-03-25
ES2044853T3 (es) 1994-01-16
ATE82016T1 (de) 1992-11-15
DK314587A (da) 1987-12-25
HUT45989A (en) 1988-09-28
ZA872863B (en) 1987-10-13
EP0250725B1 (de) 1992-11-04
JPS635089A (ja) 1988-01-11
NZ220539A (en) 1989-04-26
PT85098B (pt) 1990-03-30
EP0250725A1 (de) 1988-01-07
AU7196987A (en) 1988-01-07
DK314587D0 (da) 1987-06-19
US4757080A (en) 1988-07-12

Similar Documents

Publication Publication Date Title
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
TW221445B (el)
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
JPS57122085A (en) Circulatory disease extirpenter and use
IL79910A (en) 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them
ZA879280B (en) Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
NO162557C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner.
GR3006147T3 (el)
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
ZA888090B (en) Agents for treating high blood pressure and cardiac insufficiency
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
JPS6490158A (en) 1,2-diamino compound, manufacture and medicine for treating cardiac disease and circulatory disease